What does Indian pharma’s journey to $130 billion mean for the industry?

Pharma sector rewards investors with nearly 70 per cent returns in the last financial year amid pandemic pressure.

With the medical and pharmaceutical sector recording a galloping growth as well as a sizzling performance at the stock markets during the pandemic, it’s hardly a wonder that the industry is set to cross the $100-billion benchmark soon this decade.

The pharma sector has rewarded investors with nearly 70 per cent returns in the last financial year, during which period almost all stocks in the sector posted double-digit growth with Torrent Pharmaceuticals (92 percent), Divis Labs (80 percent) and Dr Reddy's Laboratories (45 percent) leading the pack.

Read More at https://www.indiaglobalbusiness.com/industry/health/what-does-indian-pharmas-journey-to-130-billion-mean-for-the-industry